Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 5-hydroxytryptamine receptor 1D | ||
Ligand | BDBM50473516 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1743 (CHEMBL616948) | ||
IC50 | 3.6±n/a nM | ||
Citation | Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. J Med Chem44:681-93 (2001) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
5-hydroxytryptamine receptor 1D | |||
Name: | 5-hydroxytryptamine receptor 1D | ||
Synonyms: | 5-HT-1D | 5-HT-1D-alpha | 5-HT1D | 5-hydroxytryptamine receptor 1D (5-HT1D) | 5HT1D_HUMAN | HTR1D | HTR1DA | HTRL | Serotonin (5-HT) receptor | Serotonin Receptor 1D | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 41920.63 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Receptor binding assays were performed using human clone stably expressed in CHO cells. | ||
Residue: | 377 | ||
Sequence: |
| ||
BDBM50473516 | |||
n/a | |||
Name | BDBM50473516 | ||
Synonyms: | CHEMBL2110299 | ||
Type | Small organic molecule | ||
Emp. Form. | C16H19N3O2 | ||
Mol. Mass. | 285.341 | ||
SMILES | N[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:1.0,wD:3.5,(17.46,-8.49,;16.99,-7.03,;15.61,-6.33,;16.29,-4.97,;17.67,-5.65,;15.82,-3.51,;16.71,-2.25,;15.8,-1.01,;14.33,-1.5,;13,-.73,;11.67,-1.5,;11.67,-3.04,;10.34,-3.81,;10.34,-5.35,;9.1,-6.26,;9.57,-7.71,;11.11,-7.73,;12.2,-8.82,;11.58,-6.26,;13,-3.81,;14.35,-3.04,)| | ||
Structure |